These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3086389)

  • 21. Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
    Guerra L; Condorelli AG; Fortugno P; Calabresi V; Pedicelli C; Di Zenzo G; Castiglia D
    Acta Derm Venereol; 2018 Apr; 98(4):411-415. PubMed ID: 29182795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermolysis bullosa acquisita: an autoimmune disease with distinctive immunoultrastructural features.
    Woodley DT; Gammon WR
    Cutis; 1983 Dec; 32(6):521-7. PubMed ID: 6357643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermolysis bullosa acquisita: a clinical disorder of varied etiologies. Two cases and a review of immunologic and other reported findings.
    Wilson BD; Birnkrant AF; Beutner EH; Maize JC
    J Am Acad Dermatol; 1980 Sep; 3(3):280-91. PubMed ID: 7005274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermolysis bullosa acquisita in childhood. Differentiation from hereditary epidermolysis bullosa.
    McCuaig CC; Chan LS; Woodley DT; Rasmussen JE; Cooper KD
    Arch Dermatol; 1989 Jul; 125(7):944-9. PubMed ID: 2662910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermolysis bullosa acquisita preceding the development of systemic lupus erythematosus.
    Boh E; Roberts LJ; Lieu TS; Gammon WR; Sontheimer RD
    J Am Acad Dermatol; 1990 Apr; 22(4):587-93. PubMed ID: 2319019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoelectron microscopic findings in cicatricial pemphigoid: their significance in relation to epidermolysis bullosa acquisita.
    Nieboer C; Boorsma DM; Woerdeman MJ
    Br J Dermatol; 1982 Apr; 106(4):419-21. PubMed ID: 7041948
    [No Abstract]   [Full Text] [Related]  

  • 27. Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence.
    Gardner KM; Crawford RI
    J Cutan Med Surg; 2018; 22(1):22-24. PubMed ID: 28719980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen.
    Paller AS; Queen LL; Woodley DT; Gammon WR; O'Keefe EJ; Briggaman RA
    J Invest Dermatol; 1985 Mar; 84(3):215-7. PubMed ID: 3882847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermolysis bullosa acquisita associated with psoriasis vulgaris.
    Hoshina D; Sawamura D; Nomura T; Tanimura S; Abe M; Onozuka T; Kodama K; Akiyama M; Shimizu H
    Clin Exp Dermatol; 2007 Sep; 32(5):516-8. PubMed ID: 17459071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral lesions of epidermolysis bullosa acquisita.
    Nilsen R; Livden J; Thunold S
    Oral Surg Oral Med Oral Pathol; 1978 May; 45(5):749-54. PubMed ID: 353626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies.
    Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A
    J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid.
    Mooney E; Falk RJ; Gammon WR
    Arch Dermatol; 1992 Jan; 128(1):58-60. PubMed ID: 1371212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonscarring inflammatory epidermolysis bullosa acquisita with esophageal involvement and linear IgG deposits.
    Taniuchi K; Inaoki M; Nishimura Y; Mori T; Takehara K
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 2):320-2. PubMed ID: 9039210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermolysis bullosa acquisita in a 6-year-old Japanese boy.
    Hayashi K; Ueda M; Sakai M; Fujikawa Y; Tsuru K; Amagai M; Ichihashi M
    Int J Dermatol; 1998 Aug; 37(8):612-4. PubMed ID: 9732011
    [No Abstract]   [Full Text] [Related]  

  • 35. Heavy and light chain isotypes of immunoglobulin in epidermolysis bullosa acquisita.
    Mooney E; Gammon WR
    J Invest Dermatol; 1990 Sep; 95(3):317-9. PubMed ID: 2117036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acquired epidermolysis bullosa. A clinico-pathologic study].
    Rappersberger K; Konrad K; Schenk P; Tappeiner G
    Hautarzt; 1988 Jun; 39(6):355-62. PubMed ID: 3042704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease.
    Vodegel RM; Kiss M; Cjm De Jong M; Pas HH; Altmayer A; Molnar K; Husz S; Van Der Meer JB; Jonkman MF
    Eur J Dermatol; 1998 Mar; 8(2):83-5. PubMed ID: 9649654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
    Jenkins RE; Rodenas J; Bhogal BS; Black MM
    Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita.
    Gammon WR; Kowalewski C; Chorzelski TP; Kumar V; Briggaman RA; Beutner EH
    J Am Acad Dermatol; 1990 Apr; 22(4):664-70. PubMed ID: 2180996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermolysis bullosa acquisita: diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin.
    Campos M; Silvente C; Lecona M; Suárez R; Lázaro P
    Clin Exp Dermatol; 2006 Jan; 31(1):71-3. PubMed ID: 16309488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.